Abstract

Semiconductor Manufacturing International Corporation will post its quarterly results on March 26, 2026 post-Market, with investor attention centered on a revenue estimate of about 2.48 billion US dollars, earnings per share near 0.027, and margin trajectories that reflect utilization and product-mix normalization across mature-node platforms.

Market Forecast

Consensus expectations for Semiconductor Manufacturing International Corporation this quarter point to revenue of about 2.48 billion US dollars, implying approximately 5.96% year-over-year growth, and adjusted EPS around 0.027, implying roughly a 11.30% year-over-year decline; EBIT is estimated at 226.29 million US dollars, implying about 10.95% year-over-year growth. The company has not guided a gross profit margin or net profit margin figure for the quarter; the market will watch for incremental expansion aligned with higher fab loading and ongoing cost control.

The main business, Manufacture and Sale of Integrated Circuits, remains the dominant revenue engine and is expected to benefit from gradually improving utilization and a steady contribution from specialty platforms. The most promising effort within the core portfolio is the scale-up of specialty mature-node platforms tied to diversified applications, anchored by last quarter’s 2.49 billion US dollars of segment revenue and a 12.75% year-over-year increase that sets a higher base for incremental gains.

Last Quarter Review

In the previous quarter, Semiconductor Manufacturing International Corporation delivered 2.49 billion US dollars in revenue, a gross profit margin of 19.21%, net profit attributable to the parent of 173.00 million US dollars, a net profit margin of 6.95%, and adjusted EPS of 0.02, with revenue growing 12.75% year over year and EPS growing 100% year over year. A notable financial highlight was a top-line beat versus prior estimates by approximately 70.63 million US dollars and better-than-anticipated operating performance, reflecting tighter cost control and stable average selling prices.

Main business highlights: Manufacture and Sale of Integrated Circuits contributed 2.49 billion US dollars, up 12.75% year over year, supported by stable demand conditions across end-markets that consume mature-node specialty capacity.

Current Quarter Outlook

Main business: Integrated circuits manufacturing fundamentals

The core business is expected to expand revenue this quarter by an estimated 5.96% year over year to about 2.48 billion US dollars, reflecting an incremental lift in wafer starts and a more balanced mix. Utilization remains a pivotal driver: with inventories lower versus last year and more predictable customer ordering, fab loading should edge up, which typically improves conversion cost absorption and supports gross margin stability. Average selling prices appear broadly stable quarter over quarter; any shift toward higher value specialty platforms can add incremental basis points to gross margin even if headline pricing is unchanged. Operationally, management has emphasized process optimization and yield enhancement to underpin cost per wafer improvements, which should be visible in operating profit metrics if wafer volumes align with plan. On the expense side, disciplined opex management and phasing of non-critical spend can help preserve operating leverage, particularly if revenue tracks the 2.48 billion US dollars estimate.

From a quarterly cadence standpoint, the company exited last quarter with momentum—revenue grew 12.75% year over year—which provides a higher base. The transition to the new quarter typically involves planned customer qualification cycles that can temporarily affect line loading; however, a diversified orderbook across applications can smooth this effect. Under conservative assumptions, gross profit margin is likely to track near the recent zone, with scope for incremental improvement contingent on mix and utilization. The market will parse commentary around order visibility into the next two quarters to gauge whether the current mid-single-digit revenue growth estimate is a floor or a midpoint.

Most promising business: Specialty mature-node platforms and mix lift

The largest incremental profit driver in the near term lies in the continued ramp of specialty mature-node platforms that serve diversified end-use categories requiring power, analog, and sensing performance rather than shrink-driven density alone. This area leverages process modules that command more resilient pricing and can improve die economics for customers with stable unit demand. As utilization improves, each incremental wafer that lands into specialty rather than baseline commodity platforms can yield a disproportionate contribution to gross profit. Last quarter’s 2.49 billion US dollars of segment revenue, up 12.75% year over year, demonstrates this mix-shift potential by establishing a stronger starting point. In the current quarter, if the company sustains this mix and fills incremental capacity with higher-value flows, EBIT leverage should track closer to the 10.95% year-over-year increase embedded in consensus.

Visibility into customer ramps tied to specialty flows also matters for earnings quality: longer program lifecycles and predictable run rates typically support steadier factory scheduling and fewer changeovers. This improves equipment uptime and yields, reinforcing cost-per-wafer trends. The quarter’s EPS estimate of 0.027 reflects both the revenue-level expansion and the assumption that the product mix does not deteriorate materially. Should specialty contributions come through at or above plan, adjusted EPS can surprise to the upside even without a headline ASP lift, as the cost structure benefits from better absorption and more efficient cycle times.

Factors most impacting the stock this quarter

The first determinant is the margin trajectory around utilization: a small change in effective loading can move gross profit margin by a meaningful number of basis points, given the capital-intensive cost base. Investors will focus on whether the 19.21% gross margin reported last quarter can be sustained or nudged higher via mix and conversion cost improvements. A second determinant is operating leverage through EBIT: with the market embedding a 226.29 million US dollars EBIT estimate and 10.95% year-over-year growth, commentary on the pace of opex and the phasing of non-urgent spend will influence how confident investors are about translating revenue gains into profit growth. A third determinant is capital deployment timing—capacity additions and associated depreciation affect unit economics; clarity on ramp schedules can help the market frame forward margin arcs. Finally, currency movements can influence reported figures in US dollars and the translation of costs; the market will listen for hedging or natural offset commentary.

Market sensitivity also centers on order visibility into the subsequent quarter. If bookings indicate that the current 5.96% year-over-year revenue growth is a conservative guidepost, the stock could respond favorably as investors re-rate the earnings trajectory. Conversely, if management signals uneven customer pulls or extended qualification windows, expectations could reset toward the lower end of the revenue range. The company’s execution around on-time delivery and yield stability remains an important qualitative input for investors this quarter, because it provides a leading indicator for gross margin resilience.

Analyst Opinions

Across published views since January 1, 2026 and up to March 19, 2026, the balance of commentary leans constructive, with roughly six-in-ten opinions positive versus four-in-ten cautious or neutral. The bullish camp emphasizes that near-term revenue growth in the mid-single digits, combined with improving factory utilization and a higher mix of specialty mature-node platforms, provides a pathway for gradual margin recovery. The majority view also highlights that EBIT growth near 10.95% year over year is achievable if opex discipline holds and conversion costs continue to trend lower.

Notable institutions in the bullish camp underscore three points. First, revenue stability appears firmer than a year ago given healthier downstream inventories; this underpins the 2.48 billion US dollars revenue estimate and reduces the risk of abrupt order variability. Second, the mix of orders skewing toward higher-value specialty platforms supports incremental gross margin lift even without headline ASP expansion. Third, the company’s ongoing efficiency work—process optimization and yield ramp—should keep unit costs aligned with the revenue trajectory, improving earnings quality. In synthesized comments, these institutions point to the observed 12.75% year-over-year revenue growth last quarter as evidence that the demand base has normalized, while the 19.21% gross margin sets a manageable bar that can be exceeded through better absorption in the current quarter.

On valuation framing, supportive analysts argue that the shares’ sensitivity to marginal changes in gross margin suggests that even modest utilization gains could drive a disproportionate earnings impact, especially with EBIT guided implicitly by consensus at 226.29 million US dollars. They also note that adjusted EPS at 0.027 embeds conservative assumptions on opex and mix; if specialty contributions surprise positively, upside to EPS is plausible without relying on broad-based pricing actions. These analysts characterize the setup as a “margin-credibility” quarter: revenue is better understood, while the test lies in translating that into operating profit progression.

The cautious minority highlights two areas to watch: the risk that order timing around customer qualifications could flatten month-on-month trends within the quarter, and the possibility that the product-mix tailwind moderates in the short term if customers rebalance inventory across sub-segments. Even within this view, baseline revenue near 2.48 billion US dollars and a gross margin around last quarter’s level are considered reasonable, implying that downside scenarios are bounded unless utilization backtracks.

Taken together, the prevailing institutional stance is constructive: the company’s revenue is expected to increase by 5.96% year over year to about 2.48 billion US dollars, adjusted EPS is modeled at 0.027 despite a tougher comparison, and EBIT growth of 10.95% year over year is seen as attainable under disciplined cost control. Most analysts expect steady execution—stable wafer volumes, incremental mix improvement, and controlled opex—to set a foundation for gradual margin expansion through the year. The quarter’s print and commentary on order visibility, capacity phasing, and cost trajectory will be used as validation points for this thesis.